Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|November 1, 1988
Theophylline pharmacokinetics in normal elderly subjectsS G Shin, D Juan, M RammohanCritical Reviews in Food Science and Nutrition|December 14, 1999
Food safety control in the Republic of KoreaN S Kwak, D Jukes, S G ShinChest|May 1, 1988
Diet-induced changes in trough theophylline concentrations in an elderly asthmatic patientD Juan, S G Shin, T Holmes, et al.Therapeutic Drug Monitoring|January 1, 1990
Impairment of theophylline clearance by a hypocaloric low-protein diet in chronic obstructive pulmonary diseaseD Juan, S G Shin, M Fisher, et al.Molecular Oral Microbiology|June 7, 2014
TBX21 participates in innate immune response by regulating Toll-like receptor 2 expression in Streptococcus pneumoniae infectionsC H Woo, S G Shin, S H Koh, et al.British Journal of Clinical Pharmacology|October 1, 1991
Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populationsD R Sohn, S G Shin, C W Park, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental populationD R Sohn, K Kobayashi, K Chiba, et al.Therapeutic Drug Monitoring|June 1, 1992
Utility of a one-point (3-hour postdose) plasma metabolic ratio as a phenotyping test using metoprolol in two east Asian populationsD R Sohn, M Kusaka, S G Shin, et al.Clinical Pharmacology and Therapeutics|July 1, 1988
Acute tolerance to cocaine in humansJ J Ambre, S M Belknap, J Nelson, et al.Clinical Pharmacology and Therapeutics|July 3, 1999
Theophylline pharmacokinetics are not altered by lansoprazole in CYP2C19 poor metabolizersJ W Ko, I J Jang, J G Shin, et al.Pageof 5